CS
CTOR

Clear Street’s Citius Oncology CTOR Stock Holding History

Clear Street’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7
Closed -$74 – 1321
2023
Q2 		$74 Sell
7
-57
-89% -$595 ﹤0.01% 1227
2023
Q1 		$662 Buy
+64
New +$658 ﹤0.01% 1005

Other funds holding CTOR

WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Clear Street's CTOR Position: Q3 2023 in Review

Clear Street sold out of Citius Oncology (CTOR) in Q3 2023, closing a stake of 7 shares — an estimated $74 sold.

Clear Street first reported a position in CTOR in Q1 2023 and held it in 2 quarters. The position peaked at $662 in Q1 2023. 23 funds tracked by Wall St. Rank hold CTOR as of Q3 2023.

  • Clear Street reported no remaining Citius Oncology position as of Q3 2023 after selling out during the quarter.
  • Clear Street sold 7 Citius Oncology shares in Q3 2023, an estimated $74.
  • Clear Street first reported a position in Citius Oncology in Q1 2023 and held it in 2 quarters.
  • Clear Street's Citius Oncology position peaked at $662 in Q1 2023.
  • 23 funds tracked by Wall St. Rank held Citius Oncology as of Q3 2023.

Based on Clear Street's 13F filing for Q3 2023, filed 13 Nov 2023.